These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17503884)

  • 41. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
    Arntz HR; Agrawal R; Wunderlich W; Schnitzer L; Stern R; Fischer F; Schultheiss HP
    Am J Cardiol; 2000 Dec; 86(12):1293-8. PubMed ID: 11113401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.
    Rouleau J
    Am J Med; 2005 Dec; 118 Suppl 12A():28-35. PubMed ID: 16356805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
    Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.
    Murphy SA; Cannon CP; Blazing MA; Giugliano RP; White JA; Lokhnygina Y; Reist C; Im K; Bohula EA; Isaza D; Lopez-Sendon J; Dellborg M; Kher U; Tershakovec AM; Braunwald E
    J Am Coll Cardiol; 2016 Feb; 67(4):353-361. PubMed ID: 26821621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-hospital initiation of statin therapy in acute coronary syndromes: maximizing the early and long-term benefits.
    Fonarow GC
    Chest; 2005 Nov; 128(5):3641-51. PubMed ID: 16304326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study.
    Tonkin AM; Colquhoun D; Emberson J; Hague W; Keech A; Lane G; MacMahon S; Shaw J; Simes RJ; Thompson PL; White HD; Hunt D
    Lancet; 2000 Dec; 356(9245):1871-5. PubMed ID: 11130382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
    ; Baigent C; Blackwell L; Emberson J; Holland LE; Reith C; Bhala N; Peto R; Barnes EH; Keech A; Simes J; Collins R
    Lancet; 2010 Nov; 376(9753):1670-81. PubMed ID: 21067804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is there a true beneficial effect of statin therapy in the acute phase of unstable angina or myocardial infarction?
    Correia LC
    Curr Vasc Pharmacol; 2007 Jul; 5(3):221-5. PubMed ID: 17627565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early statin treatment following acute myocardial infarction and 1-year survival.
    Stenestrand U; Wallentin L;
    JAMA; 2001 Jan 24-31; 285(4):430-6. PubMed ID: 11242427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis.
    Ebrahimi R; Saleh J; Toggart E; Shah AP; Azmoon S; Babaei H; Lee J; Smith R; Movahed MR; Rubin SA
    J Invasive Cardiol; 2008 Jun; 20(6):292-5. PubMed ID: 18523323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.
    Mega JL; Morrow DA; Cannon CP; Murphy S; Cairns R; Ridker PM; Braunwald E
    J Thromb Thrombolysis; 2006 Aug; 22(1):71-6. PubMed ID: 16786236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.
    Gómez-Gerique JA; Casciano R; Stern L; Rejas J
    Eur J Health Econ; 2004 Oct; 5(3):278-84. PubMed ID: 15714350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Rifai N; Kirtane AJ; McCabe CH; Skene AM; Gibson CM; Ridker PM; Braunwald E;
    J Am Coll Cardiol; 2005 Oct; 46(8):1417-24. PubMed ID: 16226164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndrome.
    Mukherjee D; Kline-Rogers E; Fang J; Munir K; Eagle KA
    Heart; 2005 Jan; 91(1):23-6. PubMed ID: 15604326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials.
    Afilalo J; Majdan AA; Eisenberg MJ
    Heart; 2007 Aug; 93(8):914-21. PubMed ID: 17277349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of statin pretreatment on the outcome of ST-segment elevation myocardial infarction in patients without prior history of coronary artery disease.
    Mytas D; Zairis M; Karanasos A; Kosma L; Arsenos P; Tentolouris C; Pitsavos C; Foussas S; Stefanadis C; Cokkinos D
    Hellenic J Cardiol; 2013; 54(6):422-8. PubMed ID: 24305577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.
    Ko DT; Wijeysundera HC; Jackevicius CA; Yousef A; Wang J; Tu JV
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):315-22. PubMed ID: 23674307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statins in acute coronary syndromes: do the guideline recommendations match the evidence?
    Morrissey RP; Diamond GA; Kaul S
    J Am Coll Cardiol; 2009 Oct; 54(15):1425-33. PubMed ID: 19796735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of More Intensive LDL-C-Lowering Therapy on Long-term Cardiovascular Outcomes in Early-Phase Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
    Jin S; Nie X; Li Y; Yuan J; Cui Y; Zhao L
    Clin Ther; 2021 Jul; 43(7):e217-e229. PubMed ID: 34092409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.